Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-09 Purchase | 2023-06-21 10:55 am | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director | 650,000 | $0.6 | $390,000 | 1,029,002 (Indirect Direct) | View |
| 2021-03-26 Purchase | 2021-04-01 12:22 pm | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Chairman | 95,149 | $0 | $0 | 319,624 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-21 Option Award | 2023-12-26 5:56 pm | N/A N/A | Chavant Capital Acquisition Corp. | MOBX | AUBERTON-HERVE ANDRE-JACQUES Director | 343,384 | $0 | 714,127 (Indirect) | View |
| 2023-12-21 Option Award | 2023-12-26 5:56 pm | N/A N/A | Chavant Capital Acquisition Corp. | MOBX | AUBERTON-HERVE ANDRE-JACQUES Director | 145,335 | $10 | 714,127 (Indirect) | View |
| 2023-06-13 Conversion | 2023-06-21 10:58 am | N/A N/A | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director | 186,111 | $0.6 | 1,215,114 (Indirect) | View |
| 2021-07-15 Exercise | 2022-06-21 5:49 pm | N/A N/A | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director | 7,500 | $3.16 | 442,883 (Indirect) | View |
| 2021-07-15 Exercise | 2022-06-21 5:49 pm | N/A N/A | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director | 51,878 | $3.595 | 442,883 (Indirect) | View |
| 2021-07-15 Exercise | 2022-06-21 5:49 pm | 2020-07-26 2026-07-26 | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director | 59,378 | $0 | 442,883 (Direct) | View |
| 2022-02-24 Disposition | 2022-02-28 11:38 am | N/A N/A | Chavant Capital Acquisition Corp. | CLAY | AUBERTON-HERVE ANDRE-JACQUES Director | 4,174 | $0 | 27,826 (Direct) | View |
Ownership | 2021-07-20 6:19 pm | N/A N/A | Chavant Capital Acquisition Corp. | CLAY | AUBERTON-HERVE ANDRE-JACQUES Director | 0 | $0 | 32,000 (Direct) | View |
| 2019-07-26 Option Award | 2019-08-08 3:50 pm | 2020-07-26 2026-07-26 | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director | 115,759 | $0 | 115,759 (Direct) | View |
| 2019-05-31 Option Award | 2019-06-04 3:57 pm | N/A 2026-05-31 | Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Chairman | 7,500 | $0 | 7,500 (Direct) | View |